Quest Diagnostics

Quest Diagnostics is a prominent independent clinical laboratory in the United States, specializing in diagnostic testing, information, and services essential for patients and healthcare providers. The company primarily generates its revenue from clinical testing, including anatomic pathology, esoteric testing, and substance abuse testing, with over 95% of its income derived from these areas. Specimens are collected through a national network of approximately 2,300 patient service centers, as well as various doctors' offices and hospitals. In addition to its core testing services, Quest Diagnostics operates a smaller segment focused on diagnostic solutions, which includes clinical trials testing, risk assessment services, and information technology solutions. This comprehensive approach empowers patients and doctors to make informed healthcare decisions.

Mark A. Gardner

Senior Vice President

28 past transactions

The Mercy outreach lab services business currently operates from 29 hospital laboratories and two independent clinic laboratories serving providers and patients in Arkansas, Kansas, Missouri and Oklahoma.

MACL

Acquisition in 2020
MACL is a joint venture among Quest, Ascension St. Vincent and Community Health Network that includes 50 patient service centers throughout the state.

Blueprint Genetics

Acquisition in 2020
Blueprint Genetics provides genetic diagnostics of rare diseases based on Next-Generation Sequencing (NGS). The professional genetic tests are targeted for hospitals and research groups. Blueprint Genetics aims to disrupt the market by decreasing the price level of genetic diagnostics significantly while increasing quality and adding clinical insight to the results statements. The tests are based on a novel NGS method called OS-Seq:tm: that was developed in the Stanford University. The product roadmap of the company covers a long list of diagnostics for different hereditary diseases. The currently available products cover relevant rare hereditary cardiovascular diseases, such as cardiomyopathies, arrhythmias and aorta diseases. The company is based in Helsinki, Finland and has an office also in Los Angeles, CA.

PhenoPath Laboratories

Acquisition in 2018
PhenoPath is a physician-owned, Seattle-based national pathology reference laboratory founded by Dr. Allen M. Gown, one of the world's leading experts in the diagnostic and research applications of immunohistochemistry. Since its inception in 1998, PhenoPath has grown to be a highly respected national reference laboratory embracing IHC, FISH, CISH, flow cytometric, PCR, and cytogenetics technologies. We provide screening, diagnostic, and prognostic testing services to hospitals, physician offices, surgery centers, biopharmaceutical companies, and research institutions nationwide.

ReproSource

Acquisition in 2018
ReproSource is a specialty fertility diagnostic service company. ReproSource provides a range of advanced diagnostic services, such as genetics-based ovarian health and recurrent pregnancy loss assessments, to help patients identify and surmount obstacles to fertility and pregnancy.

SomaLogic

Private Equity Round in 2018
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.
California Laboratory Associates, a clinical lab network serving patients and providers.

Cleveland HeartLab

Acquisition in 2017
Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests.

ClearPoint Diagnostic

Acquisition in 2017
ClearPoint provides physicians with routine and STAT laboratory tests, as well as anatomic and reference tests through collaboration with Pathologists Bio–Medical Laboratories and med fusion, a local reference laboratory. ClearPoint optimizes patient care through fast turn-around times, improved specimen preservation and tracking protocols, integrated information systems and highly accurate detailed reports.

Med fusion

Acquisition in 2017
Med fusion is assisting colleagues within the healthcare community to redefine the delivery of clinical laboratory and clinical trial services in a patient-centric model that uniquely integrates these services for the healthcare providers they support. They're working to change expectations for laboratory services and clinical trials. The company was founded in 2010 and is based in Lewisville, Texas.

Lemonaid Health

Series A in 2017
Lemonaid Health focuses on changing the patient experience and improving and optimizing clinical care through advancements in machine learning and AI. It leverages evidence-based guidelines and the most up-to-date clinical protocols to offer a service direct to consumers for less than typical co-pays. It was founded in 2013 and is headquartered in San Francisco, California.

PeaceHealth Laboratories

Acquisition in 2017
PeaceHealth Laboratories provides medical laboratory services to physicians, hospitals, and health care organizations.

Clinical Laboratory Partners

Acquisition in 2016
Clinical Laboratory Partners, LLC was created in 1998 through a merger of three Connecticut based laboratories.

Summit Health

Acquisition in 2014
Summit Health provides turnkey programs that minimize the time and effort their clients must invest. A key to their program success is their “single point of contact” program managers, who are assigned to work with clients from program conception through execution. Their program managers work with clients to understand their goals and customize the program based on this input to deliver outstanding customer satisfaction.

Solstas Lab Partners

Acquisition in 2014
Visitors are encouraged to comment on our page. We expect a basic level of civility and mutual respect. Profanity or abusive language are out-of-bounds as are posts that involve confidential HR matters and violate patient confidentiality.

ConVerge Diagnostic Services

Acquisition in 2013
ConVerge is a leading full-service laboratory providing clinical, cytology and anatomic pathology testing services to patients, physicians and hospitals in New England.

UMass Memorial Medical Center - Anatomic Pathology Outreach Laboratory Business

Acquisition in 2013
UMass Memorial Medical Center, Inc. comprises clinical outreach laboratory and is located in Worcester, Massachusetts.

Athena Diagnostics

Acquisition in 2011
Athena Diagnostics is a reference laboratory dedicated to the development and commercialization of diagnostic testing for neurological disorders. Using innovative technologies, Athena provides neurologists and other physicians with diagnostic answers that can improve the quality of health care for patients in a cost effective manner.

Celera

Acquisition in 2011
Celera is a healthcare business that uses knowledge of human variability to provide new tests and services to personalize disease management. Their Products business develops and manufactures molecular diagnostic products that are used by hospitals and other clinical laboratories to detect, characterize, monitor and select treatment for disease. They have a distribution agreement with Abbott, through which they develop and commercialize a wide range of molecular diagnostic products, with Abbott serving as the distribution partner.

AmeriPath

Acquisition in 2007
AmeriPath, Inc. is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers across the U.S.

HemoCue

Acquisition in 2007
HemoCue AB develops, produces, and markets medical diagnostic products for point-of-care testing. The fundamental concept behind its products is to perform important common blood and urine tests that offer lab quality results at the Point of Care without sacrificing the accuracy and precision offered by a central clinical lab. It aims to make tests fast, easy and can be performed by anyone.

Focus Diagnostics

Acquisition in 2006
Focus Diagnostics, Inc. manufactures and distributes molecular and immunology products to hospitals and commercial laboratories worldwide. Our products include the Simplexa™ molecular chemistries, HerpeSelect® type-specific serology, and a line of DxSelect™ IFA and ELISA kits to help diagnose diseases such as West Nile Virus, Rickettsia, and Legionella. An exclusive global distribution agreement between 3M and Focus Diagnostics brought the 3M Integrated Cycler and Simplexa™ molecular chemistries to the marketplace in 2009. As an organization we are committed to providing products that accommodate your laboratory’s needs through quality manufacturing practices and flexible solutions.

LabOne

Acquisition in 2005
LabOne, Inc. is a provider of medical laboratory services that caters to various sectors within the healthcare industry. The company specializes in health risk assessment services tailored for the insurance sector and offers a range of diagnostic healthcare testing to physicians, hospitals, managed care organizations, and employers. Additionally, LabOne provides drug testing services for employers and government entities, ensuring compliance and safety in workplace environments. Through its comprehensive offerings, LabOne plays a crucial role in supporting healthcare providers and organizations in managing health-related assessments and testing.

Unilab Corporation

Acquisition in 2002
Uilab is the largest independent clinical laboratory testing company in California and one of the largest in the nation. They provide efficient and competitively-priced laboratory testing services to physicians, managed care groups, hospitals and other healthcare providers. They offer over 1,000 different tests which help physicians diagnose, evaluate, monitor and treat disease by measuring the presence, concentrations or composition of chemical and cellular components in human body fluids and tissue. These tests range from routine tests, such as glucose monitoring and complete blood count, to highly specialized tests, such as those designed to measure HIV infection and hepatitis C. In 2000, they performed approximately 30 million tests. They believe that their revenues in 2000 represented approximately 25% of the California independent clinical laboratory testing market and approximately twice the annual sales of the next largest independent clinical laboratory in California.

American Medical Laboratories

Acquisition in 2002
Provides laboratory and diagnostic testing services to managed care organizations, hospitals, regional reference laboratories.

MedPlus

Acquisition in 2001
MedPlus, Inc. develops, distributes, and integrates web based clinical connectivity and healthcare information exchange solutions.

Quest Diagnostics Clinical Laboratories

Acquisition in 1997
Quest Diagnostics Clinical Laboratories, Inc. offers diagnostic testing services for physicians, hospitals, managed-care organizations.

Lancet Labs

Acquisition in 1978
Lancet Labs provides vital diagnostic and monitoring of pathology services. It operates in the private healthcare environment and offers specialist pathology services for the corporate, insurance, and mining sectors and offers an extensive range of pathology services, from sophisticated molecular and cytogenetic investigations to advanced chemical analyses. Jack Mattice, Charlie Dexter, and James Root founded Lancet Labs in Portland, Oregon.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.